Biofrontera Inc.

NASDAQ: BFRI · Real-Time Price · USD
0.93
-0.04 (-3.73%)
At close: Aug 15, 2025, 9:52 AM

Biofrontera Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
39.18M 37.99M 37.3M 35.35M 35.22M 33.22M 34.06M 33.6M 29.05M 27.66M 28.67M 27.7M 27.71M 29.11M 24.1M 23.5M 22.42M 18.97M
Cost of Revenue
15.02M 16.98M 17.86M 18.83M 18.45M 16.99M 17.64M 17.24M 14.97M 14.63M 15.19M 14.7M 14.77M 15.32M 12.74M 12.39M 11.12M 9.25M
Gross Profit
24.16M 21.01M 19.45M 16.52M 16.77M 16.23M 16.41M 16.37M 14.08M 13.02M 13.49M 13M 12.94M 13.79M 11.36M 11.11M 11.31M 9.72M
Operating Income
-16.3M -16.29M -17.21M -19.36M -19.02M -22.65M -22.88M -24.33M -25.55M -24.96M -22.38M -18.94M -29.21M -24.78M -25.2M -23.51M -9.75M -8.57M
Interest Income
46K 70K 70K 76K 72K 90K 132K 168K 158K 170K 174K 120K 121K 71K 16K 18K 21K 726K
Pretax Income
-16.57M -11.51M -17.74M -12.82M -13.49M -23.08M -20.12M -26.42M -22.64M -13.67M -608K -12.32M -25.77M -28.53M -37.66M -23.34M -10.26M -10.35M
Net Income
-16.59M -11.53M -17.76M -12.84M -13.51M -23.09M -20.13M -26.44M -22.67M -5.76M 7.28M -4.44M -17.89M -28.62M -37.71M -23.39M -10.37M -10.42M
Selling & General & Admin
35.78M 33.2M 33.79M 34.68M 34.88M 38.48M 39.05M 40.2M 39.52M 37.99M 35.87M 34.94M 44.25M 39.99M 37.2M 32.08M 19.14M 17.06M
Research & Development
3.53M 3.28M 2.09M 1.34M 704K 94K 77K 44K 11K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
1.16M 828K 794K 167K 535K 597K 398K 401K 10K -23K 33K 30K 52K 23K n/a n/a n/a n/a
Operating Expenses
40.46M 37.3M 36.68M 36.19M 36.12M 39.09M 39.49M 40.6M 39.52M 37.99M 35.87M 34.94M 44.25M 39.99M 37.2M 32.08M 19.14M 17.55M
Interest Expense
69K 804K 2.1M 2.28M 2.43M 1.93M 600K 459K 396K 367K 369K 369K 367K 364K 360K 1.03M 1.69M 1.6M
Selling & Marketing Expenses
n/a n/a n/a n/a -74K -74K -74K -74K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
55.49M 54.29M 54.53M 54.72M 54.27M 55.79M 56.84M 57.84M 54.49M 52.62M 51.05M 49.64M 59.02M 55.31M 49.94M 44.48M 30.25M 26.8M
Income Tax Expense
21K 20K 22K 18K 16K 10K 14K 21K 21K -7.91M -7.88M -7.88M -7.88M 85K 56K 49K 104K 64K
Shares Outstanding (Basic)
9.35M 5.52M 5.52M 5.77M 5.09M 3.62M 2.14M 1.37M 1.36M 1.33M 1.33M 1.14M 941.17K 855.24K 560.04K 400K 397.93K 400K
Shares Outstanding (Diluted)
9.35M 5.52M 5.52M 5.77M 5.09M 3.62M 2.14M 1.37M 1.36M 1.33M 1.33M 1.14M 941.17K 856.66K 560.33K 400K 400K 400K
EPS (Basic)
0.66 1.18 -0.94 -2.26 -5.92 -13.1 -15.82 -19.56 -17.18 -2.44 9.66 -14.15 -51.92 -68.63 -83.97 -58.53 -23.65 -20.7
EPS (Diluted)
0.66 1.18 -0.94 -2.26 -5.92 -13.1 -15.82 -19.56 -17.18 -2.44 9.65 -14.15 -51.92 -68.58 -83.91 -58.48 -23.6 -20.7
EBITDA
-16.09M -10.32M -14.48M -9.31M -9.9M -20.17M -18.72M -24.68M -21.09M -12.14M -7.86M -20.22M -33.66M -36.43M -36.76M -22.36M -8.61M -7.59M
EBIT
-11.09M -10.7M -15.63M -10.54M -11.06M -21.15M -19.52M -25.96M -22.25M -13.3M -239K -11.96M -25.4M -28.17M -37.3M -22.32M -8.57M -8.04M
Depreciation & Amortization
752K 1.06M 1.15M 1.22M 1.16M 979K 799K 1.28M 1.16M 1.17M 1.17M 525K 528K 533K 540K 548K 555K 559K